97 related articles for article (PubMed ID: 16972289)
1. Optimized synthesis of AMPA receptor antagonist ZK 187638 and neurobehavioral activity in a mouse model of neuronal ceroid lipofuscinosis.
Elger B; Schneider M; Winter E; Carvelli L; Bonomi M; Fracasso C; Guiso G; Colovic M; Caccia S; Mennini T
ChemMedChem; 2006 Oct; 1(10):1142-8. PubMed ID: 16972289
[TBL] [Abstract][Full Text] [Related]
2. Novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegeneration.
Elger B; Huth A; Neuhaus R; Ottow E; Schneider H; Seilheimer B; Turski L
J Med Chem; 2005 Jul; 48(14):4618-27. PubMed ID: 15999999
[TBL] [Abstract][Full Text] [Related]
3. Extended therapeutic time window after focal cerebral ischemia by non-competitive inhibition of AMPA receptors.
Elger B; Gieseler M; Schmuecker O; Schumann I; Seltz A; Huth A
Brain Res; 2006 Apr; 1085(1):189-94. PubMed ID: 16580649
[TBL] [Abstract][Full Text] [Related]
4. Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder.
Mennini T; Bigini P; Ravizza T; Vezzani A; Calvaresi N; Tortarolo M; Bendotti C
J Neurosci Res; 2002 Nov; 70(4):553-60. PubMed ID: 12404509
[TBL] [Abstract][Full Text] [Related]
5. Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease.
Kovács AD; Saje A; Wong A; Szénási G; Kiricsi P; Szabó E; Cooper JD; Pearce DA
Neuropharmacology; 2011; 60(2-3):405-9. PubMed ID: 20971125
[TBL] [Abstract][Full Text] [Related]
6. Moving towards therapies for juvenile Batten disease?
Cooper JD
Exp Neurol; 2008 Jun; 211(2):329-31. PubMed ID: 18400221
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, chiral resolution, and enantiopharmacology of a potent 2,3-benzodiazepine derivative as noncompetitive AMPA receptor antagonist.
Zappalà M; Postorino G; Micale N; Caccamese S; Parrinello N; Grazioso G; Roda G; Menniti FS; De Sarro G; Grasso S
J Med Chem; 2006 Jan; 49(2):575-81. PubMed ID: 16420043
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy.
Russo E; Citraro R; De Fazio S; Marra R; Gitto R; Chimirri A; De Sarro G; Di Paola ED
Epilepsy Behav; 2008 Aug; 13(2):295-9. PubMed ID: 18514580
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives.
Gitto R; Orlando V; Quartarone S; De Sarro G; De Sarro A; Russo E; Ferreri G; Chimirri A
J Med Chem; 2003 Aug; 46(17):3758-61. PubMed ID: 12904081
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, chiral resolution and pharmacological evaluation of a 2,3-benzodiazepine-derived noncompetitive AMPA receptor antagonist.
Calabrò ML; Raneri D; Ficarra P; Mennini T; Colleoni S; Grazioso G; Micale N; Zappalà M; Grasso S
ChemMedChem; 2009 Mar; 4(3):415-20. PubMed ID: 19137515
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease.
Kovács AD; Pearce DA
Exp Neurol; 2008 Jan; 209(1):288-91. PubMed ID: 17963751
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine-induced hippocampal CA1 neuron alpha-amino-3-hydroxy-5-methylisoxasole-4-propionic acid (AMPA) receptor plasticity linked to severity of withdrawal anxiety: differential role of voltage-gated calcium channels and N-methyl-D-aspartic acid receptors.
Xiang K; Tietz EI
Behav Pharmacol; 2007 Sep; 18(5-6):447-60. PubMed ID: 17762513
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of AMPA-type glutamate receptor antagonists on intermale social behavior in two mouse lines bidirectionally selected for offensive aggression.
Vekovischeva OY; Aitta-aho T; Verbitskaya E; Sandnabba K; Korpi ER
Pharmacol Biochem Behav; 2007; 87(2):241-9. PubMed ID: 17537494
[TBL] [Abstract][Full Text] [Related]
14. The effects of an AMPA receptor antagonist on the neurotoxicity of tetracaine intrathecally administered in rabbits.
Koizumi Y; Matsumoto M; Yamashita A; Tsuruta S; Ohtake T; Sakabe T
Anesth Analg; 2006 Mar; 102(3):930-6. PubMed ID: 16492854
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent.
Micale N; Colleoni S; Postorino G; Pellicanò A; Zappalà M; Lazzaro J; Diana V; Cagnotto A; Mennini T; Grasso S
Bioorg Med Chem; 2008 Mar; 16(5):2200-11. PubMed ID: 18083036
[TBL] [Abstract][Full Text] [Related]
16. In-utero and post-delivery supplementation of motor neuron degeneration mutant mice with polyunsaturated fatty acids does not alter the clinical or pathological course.
Bennett MJ; Boriack RL; Birch DG
Neuropediatrics; 1997 Feb; 28(1):82-4. PubMed ID: 9151333
[TBL] [Abstract][Full Text] [Related]
17. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists.
Gitto R; De Luca L; Pagano B; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
Bioorg Med Chem; 2008 Mar; 16(5):2379-84. PubMed ID: 18077172
[TBL] [Abstract][Full Text] [Related]
19. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis.
Herrmann P; Druckrey-Fiskaaen C; Kouznetsova E; Heinitz K; Bigl M; Cotman SL; Schliebs R
J Neurosci Res; 2008 Jun; 86(8):1857-70. PubMed ID: 18265413
[TBL] [Abstract][Full Text] [Related]
20. Decreased AMPA GluR2, but not GluR3, mRNA expression in rat amygdala and dorsal hippocampus following morphine-induced behavioural sensitization.
Sepehrizadeh Z; Bahrololoumi Shapourabadi M; Ahmadi S; Hashemi Bozchlou S; Zarrindast MR; Sahebgharani M
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1321-30. PubMed ID: 18671727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
